Quantitative in vitro screening methods are essential in drug development for measuring the hematotoxicity of novel candidates on normal and malignant hematopoietic stem and progenitor cells (HSPCs). However, these methods can be challenging and resource intensive. Explore our collection of protocols and tech tips for information on how to efficiently measure hematotoxicity with easy-to-use liquid culture-based assays.
For detailed protocols developed specifically for our products, please consult the Product Information Sheet or enter the product keyword or catalog number below.
StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not
share your email address with third parties. StemCell Technologies Inc. will use your email address to
confirm your identity and send you newsletters, transaction-related emails, promotional and customer
service emails in accordance with our privacy policy. You can change
your email preferences at any time.